1. |
- Borrebaeck, Carl A K, et al.
(författare)
-
Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?
- 1993
-
Ingår i: Immunology Today. - 0167-5699. ; 14:10, s. 477-479
-
Tidskriftsartikel (refereegranskat)abstract
- Monoclonal antibodies have many potential therapeutic benefits. However, when applied to humans, mouse monoclonal antibodies have several disadvantages. Here Carl Borrebaeck and colleagues describe a strategy to overcome the anti-Gal activity, thought to be one of the reasons why mouse mAbs have a limited half-life.
|
|
2. |
|
|
3. |
|
|
4. |
|
|
5. |
|
|
6. |
|
|
7. |
- Seliger, B, et al.
(författare)
-
TAP off--tumors on
- 1997
-
Ingår i: Immunology today. - 0167-5699. ; 18:6, s. 292-299
-
Tidskriftsartikel (refereegranskat)
|
|
8. |
|
|
9. |
|
|
10. |
- Vihinen, M, et al.
(författare)
-
BTKbase: XLA-mutation registry
- 1996
-
Ingår i: Immunology today. - 0167-5699. ; 17:11, s. 502-506
-
Tidskriftsartikel (refereegranskat)
|
|